CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Osprey Pharmaceuticals USA›
Fundraising
Osprey Pharmaceuticals USA logo

Osprey Pharmaceuticals USA

Osprey Pharmaceuticals USA: Innovating protein therapeutics for inflammatory and immune diseases.

San Francisco, CA, US🇺🇸
Founded
1998
Loading
Overview
Compare
Fundraising
Employees
Library

Osprey Pharmaceuticals USA - Funding History

Round

Date

Amount Raised

Raised To-Date

Investors

Series A
May 2009
$3,800,000
$29,692,744
0
Series Unknown
May 2009
$5,892,744
$25,892,744
0
Series A
September 2008
$11,000,000
$20,000,000
6
Debt
January 2007
$3,000,000
$9,000,000
1
Convertible Note
January 2007
$6,000,000
$6,000,000
5

Osprey Pharmaceuticals USA - Investors

Osprey Pharmaceuticals USA has raised money from at least 9 different investors as of October 11, 2026

Name

Location

Links

Type

Employees

Round(s)

Burrill & CompanyBurrill & Company
San Francisco, CA, US
LinkedIn
Investment Firm
40
Series A
Yasuda Enterprise DevelopmentYasuda Enterprise Development
Tokyo, JP
LinkedIn
Investment Firm
30
Series A
Novo NordiskNovo Nordisk
Copenhagen, Capital Region of Denmark, DK
LinkedIn
Company
55,185
Series A
BDC Venture CapitalBDC Venture Capital
Montreal, Quebec, CA
Investment Firm
3,000
Convertible NoteSeries A
Venture Lending & Leasing VVenture Lending & Leasing V
Portola Valley, CA, US
LinkedIn
Investment Firm
11
Series A
Ventures WestVentures West
Vancouver, British Columbia, CA
LinkedIn
Investment Firm
30
Convertible Note
MMV FinancialMMV Financial
Toronto, Ontario, CA
LinkedIn
Investment Firm
5
Debt
Reference Capital ManagementReference Capital Management
Portland, OR, US
-
Investment Firm
6
Convertible Note
Desjardins Venture CapitalDesjardins Venture Capital
Montreal, Quebec, CA
LinkedIn
Investment Firm
37
Convertible Note